Key Takeaways Women are more likely to survive cancer than menHowever, they also are more likely to develop severe side ...

Resistance to therapy and tumor heterogeneity remain the fundamental drivers of treatment failure in oncology. While single-agent therapies have provided ...

A discovery from Mayo Clinic researchers in Rochester shows a certain lung cancer treatment can also be used to treat aggressive cases of ovarian cancer. The study published by clinic researchers in ...

Immunotherapy has transformed cancer treatment by harnessing the body's own immune system to fight disease. But many engineered immune cells lose strength quickly after they enter the body, especially ...

Ovarian cancer (OC) is a "silent killer" with an annual incidence of 11.2 per 100,000 and mortality of 7.6 per 100,000. Most cases are diagnosed at ...

SHARJAH, 16th March, 2026 (WAM) -- A new scientific study conducted by a research team at the University of Sharjah (UoS) has found that commonly prescribed cardiovascular medications, such as blood ...

Of all the therapeutic properties attributed to C. odorata, wound healing carries the most robust body of scientific evidence ...

The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.

A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX). Published in Cell Reports, the study found ...

An innovative care delivery model at Mayo Clinic integrates virtual oversight, remote patient monitoring, mobile health ...

Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted ...